These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83 related articles for article (PubMed ID: 9476267)
21. Assessment of anti-TNF-alpha efficacy in rheumatoid arthritis: is 3 months sufficient? Pocock JM; Vasconcelos JC; Ostör AJ Rheumatology (Oxford); 2008 Jul; 47(7):1073-6. PubMed ID: 18503089 [TBL] [Abstract][Full Text] [Related]
22. [Remission induction after pentoxifylline treatment in a patient with rheumatoid arthritis]. Ishii O; Yamada H; Ohya S; Moriuchi E; Kase C; Ichikawa Y; Yamasaki K Ryumachi; 1997 Dec; 37(6):810-5. PubMed ID: 9492569 [TBL] [Abstract][Full Text] [Related]
23. Evaluating guidelines on continuation of anti-tumour necrosis factor treatment after 3 months: clinical effectiveness and costs of observed care and different alternative strategies. Kievit W; Fransen J; Adang EM; Kuper HH; Jansen TL; De Gendt CM; De Rooij DJ; Brus HL; van de Laar MA; Van Riel PC Ann Rheum Dis; 2009 Jun; 68(6):844-9. PubMed ID: 18625616 [TBL] [Abstract][Full Text] [Related]
24. Eligibility of patients in routine care for major clinical trials of anti-tumor necrosis factor alpha agents in rheumatoid arthritis. Sokka T; Pincus T Arthritis Rheum; 2003 Feb; 48(2):313-8. PubMed ID: 12571838 [TBL] [Abstract][Full Text] [Related]
25. In vivo blockade of tumor necrosis factor-alpha in patients with rheumatoid arthritis: longterm effects after repeated infusion of chimeric monoclonal antibody cA2. Lorenz HM; Grünke M; Hieronymus T; Antoni C; Nüsslein H; Schaible TF; Manger B; Kalden JR J Rheumatol; 2000 Feb; 27(2):304-10. PubMed ID: 10685789 [TBL] [Abstract][Full Text] [Related]
26. Long-term infliximab treatment in rheumatoid arthritis: subsequent outcome of initial responders. Buch MH; Bingham SJ; Bryer D; Emery P Rheumatology (Oxford); 2007 Jul; 46(7):1153-6. PubMed ID: 17478470 [TBL] [Abstract][Full Text] [Related]
27. Intravascular tumor necrosis factor alpha blockade reverses endothelial dysfunction in rheumatoid arthritis. Cardillo C; Schinzari F; Mores N; Mettimano M; Melina D; Zoli A; Ferraccioli G Clin Pharmacol Ther; 2006 Sep; 80(3):275-81. PubMed ID: 16952494 [TBL] [Abstract][Full Text] [Related]
28. Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis. Maini RN; Breedveld FC; Kalden JR; Smolen JS; Davis D; Macfarlane JD; Antoni C; Leeb B; Elliott MJ; Woody JN; Schaible TF; Feldmann M Arthritis Rheum; 1998 Sep; 41(9):1552-63. PubMed ID: 9751087 [TBL] [Abstract][Full Text] [Related]
29. An open study of pentoxyfylline and thalidomide as adjuvant therapy in the treatment of rheumatoid arthritis. Huizinga TW; Dijkmans BA; van der Velde EA; van de Pouw Kraan TC; Verweij CL; Breedveld FC Ann Rheum Dis; 1996 Nov; 55(11):833-6. PubMed ID: 8976641 [TBL] [Abstract][Full Text] [Related]
30. Clinical and laboratory changes produced by piroxicam in rheumatoid arthritis. De Zubiria RC; Charria A; Lobo Guerrero D Eur J Rheumatol Inflamm; 1983; 6(1):56-62. PubMed ID: 6861814 [TBL] [Abstract][Full Text] [Related]
31. Longterm fenoprofen therapy in patients with rheumatoid arthritis. Roth SH; Englund DW; Harris BK J Rheumatol; 1976; 2():43-8. PubMed ID: 781230 [TBL] [Abstract][Full Text] [Related]
32. Statins inhibit the antirheumatic effects of rituximab in rheumatoid arthritis: results from the Dutch Rheumatoid Arthritis Monitoring (DREAM) registry. Arts EE; Jansen TL; Den Broeder A; Vonkeman HE; Dutmer E; Van de Laar MA; Van Riel PL; Fransen J Ann Rheum Dis; 2011 May; 70(5):877-8. PubMed ID: 20956405 [No Abstract] [Full Text] [Related]
33. [Treatment of rheumatoid polyarthritis with IgG eluted from the placenta. Results of an open study on 31 patients]. Sany J; Combe B; Clot J; Andary A; Cosso B Rev Rhum Mal Osteoartic; 1986; 53(7-9):473-9. PubMed ID: 3787154 [TBL] [Abstract][Full Text] [Related]
34. Effects of oral pentoxifylline on TNF-alpha levels, transplant-related toxicities and engraftment after bone marrow transplantation. Lopez-Jimenez J; Cancelas JA; Valiño JM; Garcia-Laraña J; Garcia-Avello A; Arranz MI; Perez-Oteyza J; Ramos P; Odriozola J Bone Marrow Transplant; 1994 Dec; 14(6):1011-2. PubMed ID: 7794347 [No Abstract] [Full Text] [Related]
35. Pentoxifylline acutely reduces protein catabolism in chronically uremic patients. Biolo G; Ciocchi B; Bosutti A; Situlin R; Toigo G; Guarnieri G Am J Kidney Dis; 2002 Dec; 40(6):1162-72. PubMed ID: 12460034 [TBL] [Abstract][Full Text] [Related]
36. Phosphodiesterase inhibitor pentoxifylline: an antiinflammatory/immunomodulatory drug potentially useful in some rheumatic diseases. Anaya JM; Espinoza LR J Rheumatol; 1995 Apr; 22(4):595-9. PubMed ID: 7791149 [No Abstract] [Full Text] [Related]
37. Tumor necrosis factor-alpha levels decrease with anticytokine therapy in patients with myelodysplastic syndromes. Reza S; Shetty V; Dar S; Qawi H; Raza A J Interferon Cytokine Res; 1998 Oct; 18(10):871-7. PubMed ID: 9809623 [TBL] [Abstract][Full Text] [Related]
38. An open study of oxpentifylline in early rheumatoid arthritis. Kiely PD; Johnson D; Bourke BE Br J Rheumatol; 1998 Sep; 37(9):1033-5. PubMed ID: 9783777 [No Abstract] [Full Text] [Related]
39. Pentoxifylline as a supportive agent in the treatment of cerebral malaria in children. Di Perri G; Di Perri IG; Monteiro GB; Bonora S; Hennig C; Cassatella M; Micciolo R; Vento S; Dusi S; Bassetti D J Infect Dis; 1995 May; 171(5):1317-22. PubMed ID: 7751709 [TBL] [Abstract][Full Text] [Related]
40. Use of pentoxifylline therapy for patients with AIDS-related wasting: pilot study. Landman D; Sarai A; Sathe SS Clin Infect Dis; 1994 Jan; 18(1):97-9. PubMed ID: 8054441 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]